364 related articles for article (PubMed ID: 25381127)
1. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
[TBL] [Abstract][Full Text] [Related]
2. Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.
Karube K; Martínez D; Royo C; Navarro A; Pinyol M; Cazorla M; Castillo P; Valera A; Carrió A; Costa D; Colomer D; Rosenwald A; Ott G; Esteban D; Giné E; López-Guillermo A; Campo E
J Pathol; 2014 Nov; 234(3):423-30. PubMed ID: 25141821
[TBL] [Abstract][Full Text] [Related]
3. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G
J Exp Med; 2012 Aug; 209(9):1537-51. PubMed ID: 22891273
[TBL] [Abstract][Full Text] [Related]
4. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
5. Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.
Johansson P; Klein-Hitpass L; Grabellus F; Arnold G; Klapper W; Pförtner R; Dührsen U; Eckstein A; Dürig J; Küppers R
Oncotarget; 2016 Sep; 7(38):62627-62639. PubMed ID: 27566587
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.
Hosry J; Miranda RN; Samaniego F; Economides MP; Torres HA
Int J Cancer; 2018 Mar; 142(5):940-948. PubMed ID: 29047108
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma.
Lee SY; Kumano K; Nakazaki K; Sanada M; Matsumoto A; Yamamoto G; Nannya Y; Suzuki R; Ota S; Ota Y; Izutsu K; Sakata-Yanagimoto M; Hangaishi A; Yagita H; Fukayama M; Seto M; Kurokawa M; Ogawa S; Chiba S
Cancer Sci; 2009 May; 100(5):920-6. PubMed ID: 19445024
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
Michot JM; Canioni D; Driss H; Alric L; Cacoub P; Suarez F; Sibon D; Thieblemont C; Dupuis J; Terrier B; Feray C; Tilly H; Pol S; Leblond V; Settegrana C; Rabiega P; Barthe Y; Hendel-Chavez H; Nguyen-Khac F; Merle-Béral H; Berger F; Molina T; Charlotte F; Carrat F; Davi F; Hermine O; Besson C;
Am J Hematol; 2015 Mar; 90(3):197-203. PubMed ID: 25417909
[TBL] [Abstract][Full Text] [Related]
9. Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?
Rubio J; Franco F; Sánchez A; Cantos B; Méndez M; Calvo V; Maximiano C; Perez D; Millán I; Sánchez-Beato M; Provencio M
Leuk Lymphoma; 2015 Jun; 56(6):1686-90. PubMed ID: 25219591
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
[TBL] [Abstract][Full Text] [Related]
11. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection.
Yu SC; Lin CW
Kaohsiung J Med Sci; 2013 Mar; 29(3):150-6. PubMed ID: 23465418
[TBL] [Abstract][Full Text] [Related]
12. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
Novara F; Arcaini L; Merli M; Passamonti F; Zibellini S; Rizzi S; Rattotti S; Rumi E; Pascutto C; Vetro A; Astori C; Boveri E; Lucioni M; Paulli M; Zuffardi O; Lazzarino M
Hum Pathol; 2009 Nov; 40(11):1628-37. PubMed ID: 19647853
[TBL] [Abstract][Full Text] [Related]
13. Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors.
Shanmugam V; Craig JW; Hilton LK; Nguyen MH; Rushton CK; Fahimdanesh K; Lovitch S; Ferland B; Scott DW; Aster JC
Blood Adv; 2021 Jan; 5(1):71-83. PubMed ID: 33570635
[TBL] [Abstract][Full Text] [Related]
14. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
[TBL] [Abstract][Full Text] [Related]
16. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V
Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059
[TBL] [Abstract][Full Text] [Related]
17. Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Dlouhy I; Torrente MÁ; Lens S; Rovira J; Magnano L; Giné E; Delgado J; Balagué O; Martínez A; Campo E; Forns X; Sánchez-Tapias JM; López-Guillermo A
Ann Hematol; 2017 Mar; 96(3):405-410. PubMed ID: 28035434
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.
Nieters A; Kallinowski B; Brennan P; Ott M; Maynadié M; Benavente Y; Foretova L; Cocco PL; Staines A; Vornanen M; Whitby D; Boffetta P; Becker N; De Sanjosé S
Gastroenterology; 2006 Dec; 131(6):1879-86. PubMed ID: 17087949
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients.
Elbedewy TA; Elashtokhy HEA; Abd-Elsalam S; Suliman MA
Curr Cancer Drug Targets; 2020; 20(8):638-645. PubMed ID: 32392114
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatitis C virus infection in malignant lymphoma in Spain.
de Sanjose S; Nieters A; Goedert JJ; Domingo-Domenech E; Fernandez de Sevilla A; Bosch R; Herrera P; Domingo A; Petit J; Bosch X; Kallinowski B
Int J Cancer; 2004 Aug; 111(1):81-5. PubMed ID: 15185347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
